Charbone Corporation expanded its dedicated helium delivery fleet from one unit to five, enabling accelerated service to North American customers amid tightening global supply. The vertically integrated industrial gases company cited geopolitical disruptions to Qatar's Ras Laffan complex and shipping constraints in the Strait of Hormuz as key drivers for price volatility and urgent demand for domestic supply. This expansion supports sectors such as semiconductor manufacturing and healthcare, which require reliable ultra-high purity (UHP) industrial gases.

Operational Scale and Market Penetration

The company's growth is reflected in its rapidly expanding customer base and logistics capacity. Charbone added 22 new helium customers across Quebec recently, spanning laboratories, advanced manufacturing, and technical services. The dedicated helium trailer fleet increased from a single unit in Q4 2025 to five, with the capacity to add five more within months. This scale-up leverages Charbone's decentralized production model and infrastructure established ahead of recent market disruptions.

Strategic Positioning and Financials

Charbone secured long-term customer commitments through 2028 that insulate North American operations from volatile international shipping dependencies. The shortage has acted as a strategic market entry tool, allowing Charbone to capture market share from established competitors facing supply constraints. Management expects these new helium relationships to facilitate cross-selling of hydrogen and oxygen products. The company continues to deploy recurring revenue streams across UHP hydrogen, helium, and oxygen, supporting portfolio diversification.

Investor Relations Agreement

Charbone engaged IMPAQ Capital Inc., an independent service provider based in Montréal, Québec, to deliver investor relations services. The agreement is for an initial term of ten months, effective July 13, 2026, and will automatically renew for successive three-month periods unless terminated. IMPAQ will receive a monthly cash fee of $8,500. Additionally, the company allocated 300,000 stock options to IMPAQ from a grant announced on June 23, 2026, with an exercise price of $0.15. The options vest quarterly over a two-year period.